Alnylam Pharmaceuticals, Inc. (ALNY)

NASDAQ: ALNY · Real-Time Price · USD

303.05

-0.59 (-0.19%)

At close: Jun 5, 2026, 4:00 PM EDT

300.00

-3.05 (-1.01%)

After-hours: Jun 5, 2026, 6:40 PM EDT

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 5, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	40,461	52,639	30,424	24,078	29,451	20,381
Market Cap Growth	6.06%	73.02%	26.36%	-18.24%	44.51%	34.69%
Enterprise Value	40,422	50,964	28,984	22,903	28,537	18,902
Last Close Price	303.05	397.65	235.31	191.41	237.65	169.58
PE Ratio	76.72	170.67	-	-	-	-
Forward PE	36.20	60.03	-	-	-	-
PS Ratio	9.44	14.17	13.53	13.17	28.39	24.14
PB Ratio	37.61	66.70	453.50	-109.13	-186.13	34.65
P/TBV Ratio	38.22	67.86	447.73	-108.36	-182.78	34.15
P/FCF Ratio	62.89	113.11	-	574.04	-	-
P/OCF Ratio	56.60	100.44	-	231.18	-	-
EV/Sales Ratio	9.43	13.72	12.89	12.53	27.51	22.39
EV/EBITDA Ratio	50.09	91.46	-	-	-	-
EV/EBIT Ratio	53.74	101.61	-	-	-	-
EV/FCF Ratio	62.83	109.51	-	546.02	-	-
Debt / Equity Ratio	1.14	1.56	18.69	-5.73	-8.08	1.63
Debt / EBITDA Ratio	1.58	2.29	-	-	-	-
Debt / FCF Ratio	1.98	2.75	-	31.12	-	-
Net Debt / Equity Ratio	-1.61	-2.07	-20.84	5.14	5.51	-2.44
Net Debt / EBITDA Ratio	-2.15	-2.92	11.63	4.97	1.18	2.17
Net Debt / FCF Ratio	-2.70	-3.50	32.84	-27.03	1.42	2.00
Asset Turnover	0.85	0.81	0.56	0.50	0.29	0.24
Inventory Turnover	9.86	8.46	3.86	2.85	1.57	1.73
Quick Ratio	2.88	2.51	2.61	2.86	3.16	3.79
Current Ratio	3.13	2.76	2.78	3.08	3.51	4.04
Return on Equity (ROE)	53.88%	73.28%	362.29%	232.40%	-526.14%	-106.31%
Return on Assets (ROA)	14.67%	10.58%	-3.23%	-7.77%	-21.92%	-20.12%
Return on Invested Capital (ROIC)	62.41%	40.00%	-11.36%	-28.30%	-77.24%	-64.87%
Return on Capital Employed (ROCE)	20.66%	15.31%	-5.98%	-10.01%	-27.42%	-24.57%
Earnings Yield	1.33%	0.59%	-	-	-	-
FCF Yield	1.59%	0.88%	-	0.17%	-	-
Buyback Yield / Dilution	-6.45%	-5.51%	-2.20%	-2.64%	-2.73%	-3.01%
Total Shareholder Return	-6.45%	-5.51%	-2.20%	-2.64%	-2.73%	-3.01%

SEC Filings: 10-K · 10-Q